Hoover R David's Form 4 filing
Elanco Animal Health Inc (ELAN) · filed Mar 15, 2023
- Accession no.
- 0001415889-23-004945
- Filed
- Mar 15, 2023
- Trade date
- Mar 13-14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $95.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoover R DavidCIK 0001186033 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2023 | Common Stock | PPurchaseAcquired | +5,000 | $9.46F1 | +$47,300 | 160,000 | Indirect | |
| Mar 14, 2023 | Common Stock | PPurchaseAcquired | +5,000 | $9.55 | +$47,750 | 165,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects the weighted average price of 5,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on March 13, 2023 with purchase prices ranging from $9.455 to $9.4578 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.